Oncogenomics and the development of new cancer therapies

Robert L. Strausberg, Andrew J.G. Simpson, Lloyd J. Old, Gregory J. Riggins

Research output: Contribution to journalReview articlepeer-review

Abstract

Scientists have sequenced the human genome and identified most of its genes. Now it is time to use these genomic data, and the high-throughput technology developed to generate them, to tackle major health problems such as cancer. To accelerate our understanding of this disease and to produce targeted therapies, further basic mutational and functional genomic information is required. A systematic and coordinated approach, with the results freely available, should speed up progress. This will best be accomplished through an international academic and pharmaceutical oncogenomics initiative.

Original languageEnglish (US)
Pages (from-to)469-474
Number of pages6
JournalNature
Volume429
Issue number6990
DOIs
StatePublished - May 27 2004

ASJC Scopus subject areas

  • General

Fingerprint Dive into the research topics of 'Oncogenomics and the development of new cancer therapies'. Together they form a unique fingerprint.

Cite this